To bring bold promis­es to fruition, Mod­er­na col­lab­o­rates with Ope­nAI on Chat­G­PT tech

Last year
Deals
R&D

Drug and biotech com­pa­nies join lob­by­ing push on Chi­na bill as scruti­ny of WuXi con­tin­ues

Last year
China
Pharma

Centes­sa's pub­lic of­fer­ing; Vivory­on ends Ph2 Alzheimer’s tri­al

Last year
News Briefing

Sam­sung Bio’s bet on Plant 4 con­tin­ues to pay off with first-quar­ter earn­ings growth

Last year
Manufacturing

En­deav­or Bio­Med­i­cines snags $132M for Phase 2 fi­bro­sis drug, ADC can­di­date

Last year
Financing
Startups

Bio­gen de­tails Leqem­bi's grad­ual com­mer­cial ramp-up

Last year
Pharma

Roche dou­bles down on high-im­pact projects af­ter slash­ing 20% of its pipeline

Last year
Pharma

Dutch biotech at­tracts J&J sup­port for can­cer pipeline in $21M Se­ries A

Last year
Financing
R&D

No­var­tis brings Lu­tathera to ado­les­cents with rare can­cer in first for ra­di­oli­gand class

Last year
Pharma
FDA+

FDA gives ac­cel­er­at­ed ap­proval to Day One’s tar­get­ed treat­ment for most com­mon brain tu­mor in kids

Last year
Pharma
FDA+

In­izio Evoke Comms taps Stephanie De­Vi­teri in re­turn to agency as pres­i­dent

Last year
People
Marketing

Ver­tex li­cens­es TreeFrog’s tech to up­scale cell ther­a­py man­u­fac­tur­ing for di­a­betes can­di­dates

Last year
Deals
Pharma

Flag­ship’s gene edit­ing start­up Tessera cuts jobs as it shifts re­sources to clin­ic

Last year
People
Startups

Shi­madzu Cor­po­ra­tion es­tab­lish­es three R&D cen­ters in the US in an­tic­i­pa­tion of busi­ness ex­pan­sion for phar­ma­ceu­ti­cal ...

Last year
Manufacturing
Nikkei Biotechnology

GNI Group to form $100M fund with Chi­nese state-owned en­ter­pris­es

Last year
China
Nikkei Biotechnology

Mar­ket­ingRx roundup: Cannes ad fes­ti­val speak­ers to in­clude Pfiz­er, No­vo Nordisk; AZ adds TV com­mer­cial to NHL col­lab

Last year
Pharma
Marketing

No­var­tis’ sim­pli­fied strat­e­gy takes shape as the com­pa­ny seeks for­mer Bris­tol My­ers CEO as chair

Last year
R&D
Pharma

Brise rais­es $20M; Taro share­hold­er crit­i­cizes Sun Phar­ma deal

Last year
News Briefing

Phar­ma com­pa­nies tone down ESG men­tions, but not am­bi­tions

Last year
Pharma
Marketing

Neu­ro­crine’s de­pres­sion drug pass­es Phase 2 tri­al

Last year
R&D

Pas­cal So­ri­ot’s been push­ing for US-sized CEO pay for more than a decade. Now he’s fi­nal­ly get­ting it

Last year
People
Bioregnum

Ex­clu­sive: Marc Tessier-Lav­i­gne on leav­ing Stan­ford and join­ing biotech’s new AI mega-start­up

Last year
People
Startups

Lil­ly nabs in­jectable med­i­cines fa­cil­i­ty from Nexus Phar­ma

Last year
Pharma
Manufacturing

One bid­der and a $5 hike: How Ver­tex inked $4.9B Alpine deal

Last year
Deals
Pharma
First page Previous page 167168169170171172173 Next page Last page
A service from the Financial Times